Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TR1US: Trabectedin in First-Line Unfit STS
NCT02066675Phase 2Completed
- Sponsor
- Italian Sarcoma Group
- Start
- Feb 2014
- Primary completion
- Dec 2016
- Modality
- Covalent Small Molecules, Classical Binding Small Molecules, Nucleic Acid-Directed Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of trabectedin in soft tissue sarcoma (STS), sponsored by Italian Sarcoma Group. Started Feb 2014; status: completed.
02
Drugs
trabectedin
03
Conditions
soft tissue sarcoma (STS)
Beyond the preview
Go deeper on NCT02066675.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02066675.